Swissmedic advises caution over choice and use of blood glucose monitors:
This article was originally published in Clinica
The Swiss medical devices agency, Swissmedic, has issued a warning concerning blood glucose monitors. The notice alerts purchasers and users to the fact that some units, which are to be programmed by the patient, are badly designed in that they can lead the user to inadvertently programme a much higher dose than is correct or safe because of the two different ways of measuring the dose (in litres or decilitres). The Agency notes that the design fault is no longer present in the newer machines coming onto the market and that most manufacturers have been exchanging their systems for units which give a single, straightforward measurement reading. The notice was posted on Swissmedic's website, on September 9.